D-VRd is the only quadruplet regimen approved for patients with newly diagnosed multiple myeloma, irrespective of transplant ...

The American Academy of Pediatrics (AAP) released its 2026 child and adolescent immunization schedule, which continues to ...

To set the stage for this milestone issue, Apathy reflects on the most significant health IT advancements of the past 15 ...

ICE presence in health care settings is causing fear and healthcare avoidance, particularly among Hispanic/Latino and Somali ...

The CDC's revised schedule reduces routine vaccines from 17 to 11 diseases, with some vaccines now for high-risk groups or under shared decision-making. Experts criticize the lack of transparency and ...

Explore the operational challenges and solutions in administering bispecific therapies for follicular lymphoma, focusing on ...

Explore innovative strategies for enhancing population health through quality measures, clinician collaboration, and ...

A recent ASH study highlights the impact of CAR T and bispecific therapies on patient time commitment and quality of life in ...

Explore the vital role of interprofessional teams in primary care for managing chronic kidney disease and enhancing patient ...

Explore the promising results of the REDIRECT trial, combining bispecific therapies for treating relapsed/refractory myeloma ...

Experts discuss groundbreaking therapies in dermatology at Maui Derm 2026, addressing complex skin diseases and enhancing patient care with innovative treatments.

CMS released its 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies, proposing a net average year-over-year payment ...